Artificial Tears Improve Tear Stability
Preservative-free carboxymethyl cellulose drops modestly increased tear break-up time and produced small corneal epithelial changes in screen-exposed patients.
By
Conexiant News Staff
March 4, 2026
Clinical Scorecard: Artificial Tears Improve Tear Stability
At a Glance
Category Detail
Condition Dry eye disease associated with prolonged digital screen use
Key Mechanisms Reduced blink rate and disrupted tear film stability due to extended screen exposure
Target Population Patients aged 20 to 40 years with symptomatic dry eye disease and high daily screen exposure
Care Setting Outpatient ophthalmology or optometry clinics
Key Highlights
Preservative-free 0.5% carboxymethyl cellulose artificial tears used four times daily for 1 month improved tear film stability. Mean noninvasive tear break-up time (NIBUT) increased from 6.52 to 7.89 seconds post-treatment. Small increases in central corneal epithelial thickness (~0.86 μm) were observed, though clinical significance is uncertain.
Guideline-Based Recommendations
Diagnosis
Assess tear film stability using noninvasive tear break-up time (NIBUT) testing. Evaluate corneal epithelial structure with Fourier-domain optical coherence tomography (OCT). Consider patient history of prolonged daily screen exposure as a risk factor.
Management
Use preservative-free artificial tears containing 0.5% carboxymethyl cellulose four times daily. Advise early intervention in patients with dry eye symptoms related to digital screen use.
Monitoring & Follow-up
Monitor changes in tear film stability via NIBUT over treatment course. Observe corneal epithelial thickness changes with OCT, acknowledging limitations in measurement repeatability.
Risks
No adverse effects or conflicts of interest reported in the study. Clinical significance of small epithelial thickness changes remains uncertain.
Patient & Prescribing Data
Adults aged 20-40 years with dry eye symptoms and high screen exposure (mean 6.3 hours/day).
Artificial tears improved tear film stability significantly after 1 month; small epithelial changes noted but require further study.
Clinical Best Practices
Recommend preservative-free artificial tears to minimize ocular surface irritation. Encourage regular use (four times daily) for at least one month to observe benefits. Consider patient age and screen exposure duration when evaluating treatment response. Recognize limitations of single-arm studies and the need for longer-term follow-up.
Related Resources & Content